Scholars@Duke publication: Tumor-mediated Metabolic Re-Programing of Dendritic Cells as a Fundamental Mechanism of Immune Tolerance and Immunotherapy Resistance.

Tumor-mediated Metabolic Re-Programing of Dendritic Cells as a Fundamental Mechanism of Immune Tolerance and Immunotherapy Resistance.

Publication , Conference

Zhao, F; Evans, KS; Xiao, C; Hanks, BA

Duke Scholars

Author Brent A. Hanks Medicine, Medical Oncology

Location

Banff, Alberta, Canada

Conference Name

2016 Keystone Symposium: Immunometabolism

Citation

APA

Chicago

ICMJE

MLA

NLM

Zhao, F., Evans, K. S., Xiao, C., & Hanks, B. A. (n.d.). Tumor-mediated Metabolic Re-Programing of Dendritic Cells as a Fundamental Mechanism of Immune Tolerance and Immunotherapy Resistance. Presented at the 2016 Keystone Symposium: Immunometabolism, Banff, Alberta, Canada.

Zhao, F., K. S. Evans, C. Xiao, and B. A. Hanks. “Tumor-mediated Metabolic Re-Programing of Dendritic Cells as a Fundamental Mechanism of Immune Tolerance and Immunotherapy Resistance.,” n.d.

Zhao F, Evans KS, Xiao C, Hanks BA. Tumor-mediated Metabolic Re-Programing of Dendritic Cells as a Fundamental Mechanism of Immune Tolerance and Immunotherapy Resistance. In.

Zhao, F., et al. Tumor-mediated Metabolic Re-Programing of Dendritic Cells as a Fundamental Mechanism of Immune Tolerance and Immunotherapy Resistance.

Zhao F, Evans KS, Xiao C, Hanks BA. Tumor-mediated Metabolic Re-Programing of Dendritic Cells as a Fundamental Mechanism of Immune Tolerance and Immunotherapy Resistance.

Location

Banff, Alberta, Canada

Conference Name

2016 Keystone Symposium: Immunometabolism